Neuland Laboratories Statistics
Total Valuation
NSE:NEULANDLAB has a market cap or net worth of INR 211.11 billion. The enterprise value is 210.57 billion.
| Market Cap | 211.11B |
| Enterprise Value | 210.57B |
Important Dates
The last earnings date was Tuesday, May 12, 2026.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | Jul 18, 2025 |
Share Statistics
| Current Share Class | 12.83M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 11.52% |
| Owned by Institutions (%) | 24.97% |
| Float | 7.24M |
Valuation Ratios
The trailing PE ratio is 58.00 and the forward PE ratio is 48.16.
| PE Ratio | 58.00 |
| Forward PE | 48.16 |
| PS Ratio | 10.28 |
| PB Ratio | 11.26 |
| P/TBV Ratio | 13.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 60.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.82, with an EV/FCF ratio of -417.37.
| EV / Earnings | 57.85 |
| EV / Sales | 10.26 |
| EV / EBITDA | 34.82 |
| EV / EBIT | 41.05 |
| EV / FCF | -417.37 |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.09 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.50 |
| Debt / FCF | -5.97 |
| Interest Coverage | 21.42 |
Financial Efficiency
Return on equity (ROE) is 21.42% and return on invested capital (ROIC) is 21.59%.
| Return on Equity (ROE) | 21.42% |
| Return on Assets (ROA) | 12.55% |
| Return on Invested Capital (ROIC) | 21.59% |
| Return on Capital Employed (ROCE) | 23.11% |
| Weighted Average Cost of Capital (WACC) | 2.53% |
| Revenue Per Employee | 11.44M |
| Profits Per Employee | 2.03M |
| Employee Count | 1,794 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 2.11 |
Taxes
In the past 12 months, NSE:NEULANDLAB has paid 1.25 billion in taxes.
| Income Tax | 1.25B |
| Effective Tax Rate | 25.56% |
Stock Price Statistics
The stock price has increased by +31.25% in the last 52 weeks. The beta is -0.32, so NSE:NEULANDLAB's price volatility has been lower than the market average.
| Beta (5Y) | -0.32 |
| 52-Week Price Change | +31.25% |
| 50-Day Moving Average | 13,969.52 |
| 200-Day Moving Average | 14,679.58 |
| Relative Strength Index (RSI) | 61.29 |
| Average Volume (20 Days) | 74,724 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NEULANDLAB had revenue of INR 20.53 billion and earned 3.64 billion in profits. Earnings per share was 283.71.
| Revenue | 20.53B |
| Gross Profit | 11.06B |
| Operating Income | 5.13B |
| Pretax Income | 4.89B |
| Net Income | 3.64B |
| EBITDA | 6.05B |
| EBIT | 5.13B |
| Earnings Per Share (EPS) | 283.71 |
Balance Sheet
The company has 3.55 billion in cash and 3.01 billion in debt, with a net cash position of 536.93 million.
| Cash & Cash Equivalents | 3.55B |
| Total Debt | 3.01B |
| Net Cash | 536.93M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 18.74B |
| Book Value Per Share | 1,460.99 |
| Working Capital | 7.73B |
Cash Flow
In the last 12 months, operating cash flow was 3.47 billion and capital expenditures -3.97 billion, giving a free cash flow of -504.52 million.
| Operating Cash Flow | 3.47B |
| Capital Expenditures | -3.97B |
| Depreciation & Amortization | 917.40M |
| Net Borrowing | 603.66M |
| Free Cash Flow | -504.52M |
| FCF Per Share | n/a |
Margins
Gross margin is 53.87%, with operating and profit margins of 24.98% and 17.73%.
| Gross Margin | 53.87% |
| Operating Margin | 24.98% |
| Pretax Margin | 23.82% |
| Profit Margin | 17.73% |
| EBITDA Margin | 29.45% |
| EBIT Margin | 24.98% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 0.07%.
| Dividend Per Share | 12.00 |
| Dividend Yield | 0.07% |
| Dividend Growth (YoY) | -14.29% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 4.23% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.07% |
| Earnings Yield | 1.72% |
| FCF Yield | -0.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |